Breaking News, Financial News

Financial Report: AMRI 4Q

Contract revenue for the quarter, which includes Discovery Services, Development and Small Scale Manufacturing, and Large Scale Manufacturing, was $49.6 million (+22%) and $195.5 million for the year (+20%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

4Q Revenues: $56.4 million (+19%)

4Q Earnings: $3.1 million (loss of $800,000 in 4Q07)

FY Revenues: $229.3 million (+19%)

FY Earnings: $20.6 million (+130%)

Comments: Contract revenue for the quarter, which includes Discovery Services, Development and Small Scale Manufacturing, and Large Scale Manufacturing, was $49.6 million (+22%) and $195.5 million for the year (+20%). Discovery Services revenue was $13.1 million in the quarter (+13%) and $57.8 million for the year (+39%). Development/Small Scale Manufacturing revenue was $13.2 million in the quarter (+16%) and $56.2 million for the year (+24%). Large Scale Manufacturing revenue was $23.3 million in the quarter (+32%) and $81.5 million for the year (+7%). Royalties from Allegra in quarter were $6.8 million (+11%) and $28.3 million for the year (+5%). Milestone revenue from the company’s 2005 licensing agreement with Bristol-Myers Squibb was $5.5 million for the year, compared to $1.5 million in 2007.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters